GlassScriptPhysician profile
Caleb A Kennon
NPI 1144789918
$4,914.68
in general payments reported to CMS, 2019-2025
9 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,901 · 2024: $1,342 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,155 · Travel and Lodging: $1,625 · Education: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,154.59 |
| Travel and Lodging | $1,625.29 |
| Education | $1,134.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,947.43 | 2023-2024 | Senza |
| Abbott Laboratories | $1,158.34 | 2024-2025 | Proclaim, Eterna, Durata |
| Spinal Simplicity, LLC | $1,077.89 | 2024-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $275.59 | 2024 | Wavewriter Alpha Prime 16, Intracept |
| Painteq LLC | $166.13 | 2023 | Painteq |
| Tersera Therapeutics LLC | $120.82 | 2024 | Prialt |
| Stryker Corporation | $82.49 | 2024-2025 | Multigen 2, Spinejack, Mild Device Kit |
| Medtronic, INC. | $54.71 | 2025 | Inceptiv |
| Nalu Medical, INC. | $31.28 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Kennon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.